Exact Sciences Corp.

Exact Sciences offers industry‑leading Cologuard stool‑based DNA test and Oncotype DX tumor‑profiling assays for breast, prostate and colon cancer, backed by Mayo and Johns Hopkins licenses. Its pipeline targets blood‑based screening and early diagnosis.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 6,900
HQ: Madison

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
EXAS	Exact Sciences Corp. Cap: 19.4B	EQUITY	NMS	USD	US30063P1057	Active	📈